How to Value a Dental Implant Practice

Dental implant practices — particularly those focused on full-arch rehabilitation like All-on-4, All-on-6, and implant-supported dentures — are among the highest-revenue-per-provider practices in all of dentistry. A single full-arch case generates $15,000-$35,000 in revenue, and a busy implant center doing 8-15 full-arch cases per month can produce $3M-$8M+ in annual revenue with a single surgeon and a small team.

That revenue concentration creates both enormous upside and unique valuation challenges. I've worked on implant practice transactions ranging from $2M to $25M+, and the spread between what a poorly-positioned practice sells for versus a well-structured one is wider than almost any other dental niche.

The Multiple Range: 5-10x EBITDA

Implant-focused practices currently trade at 5-10x EBITDA, with the occasional outlier above 10x for multi-provider operations with strong brand recognition. Compared to general dental practices (which trade at 5-7x EBITDA for DSO transactions and 60-85% of collections for private sales), implant practices command a premium for one simple reason: the revenue per chair hour is 3-5x higher.

A general dentist producing $600K-$800K per year is solid. An implant surgeon producing $2M-$4M per year in the same number of chair hours is exceptional. That production capacity makes implant practices attractive to private equity groups and DSOs building specialty platforms.

Where you land in the 5-10x range depends on six factors I'll walk through below. But the short version: practices with multiple providers, proven marketing systems, in-house lab capabilities, and consistent case volume sit at the top. Solo-surgeon operations with lumpy month-to-month production sit at the bottom.

Case Volume Is Everything

In general dentistry, buyers look at collections and active patient count. In implant dentistry, they look at case volume first. Specifically: how many full-arch cases per month, what's the average case fee, and what does the trend look like over 24 months?

Here's the rough hierarchy:

• 4-6 full-arch cases/month: Good. Sustainable single-surgeon practice. Revenue in the $1.5M-$3M range. Valued at 5-7x.
• 8-12 full-arch cases/month: Strong. Likely maxing out one surgeon, may have a second provider. Revenue $3M-$5M. Valued at 6-8x.
• 15+ full-arch cases/month: Elite. Multi-provider, systematized operation with dedicated treatment coordinators and marketing infrastructure. Revenue $5M+. Valued at 8-10x.

The caveat: these numbers assume full-arch is the primary revenue driver. Many implant practices also do single-tooth implants ($3,000-$5,000 each), implant-supported bridges, and bone grafting. That's fine — a diversified case mix is actually a positive. But the full-arch volume is what sophisticated buyers underwrite first because it drives the economics of the entire practice.

Average Case Fee and Fee Structure

Full-arch case fees vary dramatically by market, material choice, and practice positioning. I've seen fees ranging from $12,000 (high-volume, acrylic-only practices in competitive markets) to $45,000+ (zirconia full-arch in affluent metros with premium positioning).

The sweet spot for most successful practices is $18,000-$28,000 per arch for an All-on-4 with a fixed hybrid prosthesis. At that price point, you're accessible enough to generate volume but not so cheap that you're attracting purely price-sensitive patients who create operational headaches.

Buyers also scrutinize how fees are collected. Patient financing through companies like Proceed Finance, CareCredit, or in-house payment plans is standard in this space — most patients aren't writing $25K checks. The percentage of cases financed, default rates on in-house financing, and whether the practice takes the financing risk or sells it to a third party all affect how buyers model cash flow.

Marketing Spend and Patient Acquisition Cost

This is where implant practices diverge most from general dentistry. A GP practice might spend $2,000-$5,000/month on marketing. A full-arch implant practice routinely spends $30,000-$80,000/month on digital marketing — Google Ads, Meta ads, YouTube pre-roll, and SEO content targeting keywords like "All-on-4 near me" and "dental implants [city]."

The patient acquisition cost for a full-arch case typically runs $500-$2,000, depending on market competitiveness. In saturated markets like South Florida, Phoenix, or DFW, I've seen acquisition costs push to $2,500+. In less competitive mid-tier markets, $400-$800 is achievable.

What buyers want to see: a documented, repeatable marketing system with clear ROI metrics. If your practice generates 80+ qualified implant leads per month through proven channels, that marketing machine has real value — arguably as much value as the clinical operation itself. If your lead flow depends entirely on referrals from one oral surgery group or your personal reputation, that's fragile and buyers will discount accordingly.

In-House Lab Integration

The most valuable implant practices I've seen all have one thing in common: they control their lab work. An in-house dental lab that mills zirconia prosthetics, fabricates surgical guides (using CBCT and digital workflow), and handles all prosthetic finishing in-house accomplishes three things at once.

First, it compresses turnaround time. Patients can get their immediate-load prosthesis the same day as surgery rather than waiting 2-3 weeks for an external dental lab to ship it. That's a better patient experience and a major marketing advantage.

Second, it dramatically improves margins. An external lab charges $2,000-$4,000 per full-arch prosthesis. In-house fabrication costs $400-$800 in materials. On 10 cases per month, that's $15,000-$30,000 in monthly margin improvement.

Third, it creates a barrier to entry. Setting up a dental milling lab requires $150K-$300K in equipment (CAD/CAM software, milling machines, sintering ovens, 3D printers) plus trained technicians. That investment deters competition and gives buyers confidence in the practice's cost structure.

Technology and Clinical Infrastructure

Buyers evaluating implant practices expect to see specific technology investments that signal a modern, efficient operation:

• CBCT scanner ($100K-$200K) — essential for treatment planning. If you don't have one, you're referring out for imaging, which is inefficient and loses revenue.
• Digital surgical guide workflow — guided implant placement reduces complications, improves outcomes, and enables less experienced associates to place implants safely.
• Intraoral scanners ($30K-$50K) — eliminates traditional impressions, integrates with digital lab workflow.
• IV sedation capability — most full-arch patients want sedation. If your practice can't provide it in-house (requiring proper licensing, monitoring equipment, and trained staff), you're losing cases to practices that can.

The total technology investment in a well-equipped implant practice runs $300K-$600K. That's a significant asset base, but buyers value these assets at depreciated book value, not replacement cost. What they really value is the clinical workflow these tools enable — specifically, how many cases can be completed per day with high quality and low complication rates.

The Provider Dependency Problem

This is the single biggest risk factor in implant practice valuation. Full-arch implant surgery is a high-skill procedure. Not every dentist can do it. Many implant practices are built entirely around one surgeon's skill and reputation. When that surgeon leaves, the case volume doesn't just decline — it can evaporate.

Practices with a single implant surgeon who places and restores all cases are inherently worth less than multi-provider operations. The solution isn't easy: finding and retaining implant surgeons is difficult, and training associates to perform full-arch procedures takes 12-24 months of mentorship.

If you're planning to sell, the most impactful thing you can do is bring on a second surgeon 18-24 months before going to market. Even if that surgeon handles only 30-40% of cases, it proves the practice can function with a different clinician. That proof alone can add 1-2 turns to your EBITDA multiple.

Who's Buying Implant Practices

The buyer landscape is different from general dentistry. Traditional DSOs like Heartland or Aspen aren't typically the lead buyers for high-end implant practices — the clinical model doesn't fit their GP-centric platform.

Instead, I see three primary buyer types. Specialty-focused DSOs like ClearChoice (acquired by Aspen for $1.1B in 2023), Nuvia Dental, and regional implant platforms are the most active. They're building networks of implant centers and will pay 7-10x for practices that fit their model. Private equity groups looking to create new specialty platforms pay similar multiples for anchor acquisitions. Individual oral surgeons or prosthodontists buying with SBA financing represent the lower end of the multiple range (5-7x) but can close faster with fewer complications.

The Bottom Line

Dental implant practices sit at the premium end of dental specialty valuations because the revenue per provider is exceptional and the demand for full-arch rehabilitation continues to grow as the population ages. But the valuation spread is wide — a disorganized, single-surgeon practice dependent on referrals might sell for 5x EBITDA, while a multi-provider operation with a proven marketing engine, in-house lab, and consistent 10+ case months can command 9-10x.

The practices that sell at the top of the range all share three traits: multiple providers, a repeatable patient acquisition system, and lab integration. If you're building toward an exit, those are the levers to pull.